Granula Therapeutics: Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases
Clinical candidate selection finalised for lead programme targeting mast-cell driven diseases Dermatology industry veteran Thibaud Portal, PhD appointed as CEO LONDON, March 30, 2023
Source: finanznachrichten.de